Fiscal Year 2020 Superfund Budget
(Dollars in Thousands)
MECHANISM | FY 2018 Final4 |
FY 2019 Enacted5 |
FY 2020 President's Budget6 |
FY 2020 +/- FY 2019 |
||||
---|---|---|---|---|---|---|---|---|
No. | Amount | No. | Amount | No. | Amount | No. | Amount | |
Research Projects: | ||||||||
Noncompeting | 25,858 | $13,776,726 | 27,492 | $14,677,360 | 28,760 | $14,536,572 | 1,268 | -$140,788 |
Administrative Supplements3 | (2,743) | 483,035 | (2,695) | 506,430 | (1,858) | 361,166 | (-837) | -145,264 |
Competing | 11,461 | $5,943,802 | 11,675 | $6,311,423 | 7,894 | $3,725,852 | -3,781 | -$2,585,571 |
Subtotal, RPGs | 37,319 | $20,203,562 | 39,167 | $21,495,213 | 36,654 | $18,623,590 | -2,513 | $2,871,623 |
SBIR/STTR | 2,035 | 1,001,946 | 2,222 | 1,084,179 | 1,911 | 921,133 | -311 | -163,046 |
Research Project Grants | 39,354 | $21,205,508 | 41,389 | $22,579,392 | 38,565 | $19,544,723 | -2,824 | -$3,034,669 |
Research Centers: | ||||||||
Specialized/Comprehensive | 1,003 | $1,813,976 | 1,079 | $1,908,419 | 924 | $1,547,608 | -155 | -$360,811 |
Clinical Research | 68 | 417,709 | 66 | 421,640 | 64 | 362,000 | -2 | -59,640 |
Biotechnology | 91 | 159,963 | 91 | 160,916 | 80 | 138,518 | -11 | -22,398 |
Comparative Medicine | 67 | 129,881 | 79 | 133,759 | 67 | 115,233 | -12 | -18,526 |
Research Centers in Minority Institutions | 21 | 61,478 | 20 | 63,407 | 20 | 54,594 | 0 | -8,814 |
Research Centers | 1,250 | $2,583,007 | 1,335 | $2,688,141 | 1,155 | $2,217,953 | -180 | -$470,188 |
Other Research: | ||||||||
Research Careers | 4,040 | $747,017 | 4,161 | $780,492 | 3,792 | $708,160 | -369 | -$72,332 |
Cancer Education | 76 | 21,182 | 85 | 24,857 | 81 | 23,614 | -4 | -1,243 |
Cooperative Clinical Research | 229 | 409,660 | 278 | 497,025 | 243 | 411,324 | -35 | -85,701 |
Biomedical Research Support | 118 | 85,524 | 112 | 73,696 | 95 | 62,825 | -17 | -10,872 |
Minority Biomedical Research Support | 283 | 101,245 | 294 | 104,359 | 228 | 81,111 | -66 | -23,248 |
Other | 2,064 | 1,081,442 | 2,066 | 1,009,259 | 1,805 | 922,686 | -261 | -86,572 |
Other Research | 6,810 | $2,446,070 | 6,996 | $2,489,688 | 6,244 | $2,209,720 | -752 | -$279,968 |
Total Research Grants | 47,414 | $26,234,584 | 49,720 | $27,757,221 | 45,964 | $23,972,395 | -3,756 | -$3,784,825 |
Ruth L. Kirschstein Training Awards | FTTPs | FTTPs | FTTPs | FTTPs | ||||
Individual Awards | 3,500 | $161,753 | 3,697 | $173,134 | 3,335 | $157,779 | -362 | -$15,355 |
Institutional Awards | 12,697 | 694,093 | 12,969 | 715,821 | 11,657 | 644,094 | -1,312 | -71,727 |
Total Research Training | 16,197 | $855,845 | 16,666 | $888,955 | 14,992 | $801,873 | -1,674 | -$87,082 |
Research & Develop. Contracts | 2,212 | $3,072,532 | 2,177 | $3,132,619 | 1,862 | $2,795,430 | -315 | -$337,189 |
SBIR/STTR (non-add)3 | (85) | (60,608) | (98) | (74,336) | (79) | (64,122) | (-19) | (-10,214) |
Intramural Research | $3,996,276 | $4,129,550 | $3,633,805 | -$495,745 | ||||
Res. Management & Support | 1,816,210 | 1,898,356 | 1,739,376 | -158,979 | ||||
Res. Management & Support (SBIR Admin) (non-add)3 | (0) | (5,172) | (3,559) | (-1,613) | ||||
Office of the Director - Appropriation3,7 | (1,914,345) | (2,112,675) | (1,926,144) | (-186,531) | ||||
Office of the Director - Other | 1,024,420 | 1,204,300 | 1,144,168 | -60,132 | ||||
ORIP (non-add)3,7 | (289,209) | (289,209) | (249,009) | (-40,200) | ||||
Common Fund (non-add)3,7 | (600,716) | (619,166) | (532,967) | (-86,199) | ||||
Buildings and Facilities8 | 146,863 | 218,000 | 214,000 | -4,000 | ||||
Appropriation3 | (128,863) | (200,000) | (200,000) | 0 | ||||
Type 1 Diabetes9 | -150,000 | -150,000 | -150,000 | 0 | ||||
Program Evaluation Financing9 | -922,871 | -1,146,821 | -741,000 | 405,821 | ||||
Subtotal, Labor/HHS Budget Authority | $36,073,860 | $37,932,179 | $33,410,048 | -$4,522,131 | ||||
Interior Appropriation for Superfund Research10 | 77,349 | 77,349 | 66,581 | -10,768 | ||||
Total, NIH Discretionary Budget Authority | $36,151,209 | $38,009,528 | $33,476,629 | -$4,532,899 | ||||
Type 1 Diabetes | 150,000 | 150,000 | 150,000 | 0 | ||||
Total, NIH Budget Authority | $36,301,209 | $38,159,528 | $33,626,629 | -$4,532,899 | ||||
Program Evaluation Financing | 922,871 | 1,146,821 | 741,000 | -405,821 | ||||
Total, Program Level | $37,224,080 | $39,306,349 | $34,367,629 | -$4,938,720 |
1 All Subtotal and Total numbers may not add due to rounding.
2 Includes 21st Century Cures Act funding and excludes Ebola-related and supplemental financing.
3 All numbers in italics and brackets are non-add.
4 Includes $63.3 million of 21st Century Cures, $428.9 million of Opioids, and $123.7 million of Type 1 Diabetes funding not obligated in FY 2018, and carried over into FY 2019. Numbers of grants and dollars for carryover are distributed by mechanism.
5 Reflects transfer of $5.0 million to the HHS OIG.
6 Includes funding for National Institute for Research on Safety and Quality (formerly the Agency for Healthcare Research and Quality) distributed by mechanism.
7 Number of grants and dollars for the Common Fund and ORIP components of OD are distributed by mechanism and are noted here as non-adds. Office of the Director - Appropriation is the non-add total of these amounts and the funds accounted for under OD - Other.
8 Includes B&F appropriation and monies allocated ($18.0 million in FY 2018, $18.0 million in FY 2019, and $14.0 million in FY 2020) pursuant to appropriations acts provisions that funding may be used for facilities repairs and improvements at the NCI Federally Funded Research and Development Center in Frederick, Maryland.
9 Amounts for AHRQ and PCORTF are shown in FY 2018 and FY 2019 to produce comparable tools for NIH budget authority and program level. Amounts are not distributed by mechanism.
10 Number of grants and dollars for mandatory Type 1 Diabetes (TID) and NIGMS Program Evaluation financing are distributed by mechanism above; therefore, TID and Program Evaluation financing amounts are deducted to provide subtotals for Labor/HHS Budget Authority.
11 This activity was under a Continuing Resolution at the time the budget estimates were prepared.
to Top